Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03237572
Title Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer (Breast-48)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Patrick Dillon, MD
Indications

breast cancer

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.